Hongbo Lu - Net Worth and Insider Trading
Hongbo Lu Net Worth
The estimated net worth of Hongbo Lu is at least $138 Million dollars as of 2024-11-10. Hongbo Lu is the Director of Turning Point Therapeutics Inc and owns about 1,727,550 shares of Turning Point Therapeutics Inc (TPTX) stock worth over $131 Million. Hongbo Lu is the Director of Terns Pharmaceuticals Inc and owns about 666,666 shares of Terns Pharmaceuticals Inc (TERN) stock worth over $5 Million. Hongbo Lu is also the Director of Zenas BioPharma Inc and owns about 58,823 shares of Zenas BioPharma Inc (ZBIO) stock worth over $1 Million. Besides these, Hongbo Lu also holds Arrowhead Pharmaceuticals Inc (ARWR) . Details can be seen in Hongbo Lu's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hongbo Lu has not made any transactions after 2024-09-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Hongbo Lu
Hongbo Lu Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hongbo Lu owns 3 companies in total, including Avedro Inc (AVDR) , Turning Point Therapeutics Inc (TPTX) , and Terns Pharmaceuticals Inc (TERN) .
Click here to see the complete history of Hongbo Lu’s form 4 insider trades.
Insider Ownership Summary of Hongbo Lu
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVDR | Avedro Inc | 2019-11-21 | director |
| TPTX | Turning Point Therapeutics Inc | 2019-04-22 | director |
| TERN | Terns Pharmaceuticals Inc | 2024-09-12 | director |
Hongbo Lu Latest Holdings Summary
Hongbo Lu currently owns a total of 4 stocks. Among these stocks, Hongbo Lu owns 1,727,550 shares of Turning Point Therapeutics Inc (TPTX) as of April 22, 2019, with a value of $131 Million and a weighting of 95.05%. Hongbo Lu owns 666,666 shares of Terns Pharmaceuticals Inc (TERN) as of September 12, 2024, with a value of $5 Million and a weighting of 3.52%. Hongbo Lu also owns 58,823 shares of Zenas BioPharma Inc (ZBIO) as of September 13, 2024, with a value of $1 Million and a weighting of 0.89%. The other 1 stocks Arrowhead Pharmaceuticals Inc (ARWR) have a combined weighting of 0.53% among all his current holdings.
Latest Holdings of Hongbo Lu
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TPTX | Turning Point Therapeutics Inc | 2019-04-22 | 1,727,550 | 76.01 | 131,311,076 |
| TERN | Terns Pharmaceuticals Inc | 2024-09-12 | 666,666 | 7.30 | 4,866,662 |
| ZBIO | Zenas BioPharma Inc | 2024-09-13 | 58,823 | 21.00 | 1,235,283 |
| ARWR | Arrowhead Pharmaceuticals Inc | 2024-03-20 | 33,680 | 21.89 | 737,255 |
Holding Weightings of Hongbo Lu
Hongbo Lu Form 4 Trading Tracker
According to the SEC Form 4 filings, Hongbo Lu has made a total of 0 transactions in Turning Point Therapeutics Inc (TPTX) over the past 5 years. The most-recent trade in Turning Point Therapeutics Inc is the acquisition of 60,000 shares on April 22, 2019, which cost Hongbo Lu around $1 Million.
According to the SEC Form 4 filings, Hongbo Lu has made a total of 4 transactions in Terns Pharmaceuticals Inc (TERN) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Terns Pharmaceuticals Inc is the acquisition of 476,190 shares on September 12, 2024, which cost Hongbo Lu around $5 Million.
According to the SEC Form 4 filings, Hongbo Lu has made a total of 1 transactions in Zenas BioPharma Inc (ZBIO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Zenas BioPharma Inc is the acquisition of 58,823 shares on September 13, 2024, which cost Hongbo Lu around $999,991.
More details on Hongbo Lu's insider transactions can be found in the Insider Trading History of Hongbo Lu table.Insider Trading History of Hongbo Lu
- 1
Hongbo Lu Trading Performance
GuruFocus tracks the stock performance after each of Hongbo Lu's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hongbo Lu is 17.7%. GuruFocus also compares Hongbo Lu's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hongbo Lu within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Hongbo Lu's insider trading performs compared to the benchmark.
Performance of Hongbo Lu
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.83 | | | | | |
| Relative Return to S&P 500(%) | 13.75 | | | | | |
Hongbo Lu Ownership Network
Ownership Network List of Hongbo Lu
Ownership Network Relation of Hongbo Lu
Hongbo Lu Owned Company Details
What does Avedro Inc do?
Who are the key executives at Avedro Inc?
Hongbo Lu is the director of Avedro Inc. Other key executives at Avedro Inc include 10 percent owner Arnold L Oronsky , 10 percent owner Gilbert H Kliman , and General Counsel and Sec. Paul S Bavier .
Avedro Inc (AVDR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Avedro Inc (AVDR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Avedro Inc (AVDR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Avedro Inc (AVDR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avedro Inc Insider Transactions
Hongbo Lu Mailing Address
Above is the net worth, insider trading, and ownership report for Hongbo Lu. You might contact Hongbo Lu via mailing address: C/o Avedro, Inc., 201 Jones Road, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
